Exenatide ameliorates experimental non-alcoholic fatty liver in rats via suppression of toll-like receptor 4/NFκB signaling: Comparison to metformin

This publication has 54 references indexed in Scilit:

• Metformin: an old but still the best treatment for type 2 diabetes
  Diabetology & Metabolic Syndrome, 2013
• Physiology and Emerging Biochemistry of the Glucagon-Like Peptide-1 Receptor
  Experimental Diabetes Research, 2012
• Medicinal Chemistry and Applications of Incretins and DPP-4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
  The Open Medicinal Chemistry Journal, 2011
• Therapy in the Early Stage: Incretins
  Diabetes Care, 2011
• Artesunate Activates Mitochondrial Apoptosis in Breast Cancer Cells via Iron-catalyzed Lysosomal Reactive Oxygen Species Production
  Journal of Biological Chemistry, 2011
• Metformin restores endothelial function in aorta of diabetic rats
  British Journal of Pharmacology, 2011
• Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits
  Diabetes Care, 2010
• Exaggerated liver injury induced by renal ischemia reperfusion in diabetes: Effect of exenatide
  Saudi Journal of Gastroenterology, 2010
• The Role of Incretins in Glucose Homeostasis and Diabetes Treatment
  Pharmacological Reviews, 2008
• TLR4 links innate immunity and fatty acid–induced insulin resistance
  Journal of Clinical Investigation, 2006